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Abstract
Background: The pervasiveness of doping and findings of anti-doping corruption threaten weightlifting’s position
at the 2024 Olympic Games. Analysing the practices of doping in weightlifters could identify patterns in doping
that assist in future detection.
Methods: We analysed publicly available data on sanctioned athletes/support personnel from the International
Weightlifting Federation between 2008 and 2019 and announced retrospective Anti-Doping Rule Violations (ADRVs)
from the 2008 and 2012 Olympic Games.
Results: There were 565 sanctions between 2008 and 2019 of which 82% related to the detection of exogenous
Anabolic Androgenic Steroid (AAS) metabolites and markers indicating endogenous AAS usage. The detection of
exogenous AAS metabolites, markers of endogenous AAS usage and other substance metabolites varied by IWF
Continental Federation (p ≤ 0.05) with Europe (74%, 11%, 15%) and Asia (70%, 15%, 15%) showing a higher
detection of exogenous AAS compared to Pan America (37%, 30%, 33%) and Africa (50%, 17%, 33%). When looking
at the 10 most detected substances, the nations with the highest number of sanctions (range 17–35) all had at
least one overrepresented substance that accounted for 38–60% of all detected substances. The targeted re-analysis
of samples from the 2008 and 2012 Olympic Games due to the discovery of long-term metabolites for exogenous
AAS resulted in 61 weightlifters producing retrospective ADRVs. This includes 34 original medallists (9 gold, 10 silver
and 15 bronze), the highest of any sport identified by Olympic Games sample re-testing. The exogenous AAS
dehydrochloromethyltestosterone and stanozolol accounted for 83% of detected substances and were present in
95% of these samples.
Conclusion: Based on these findings of regional differences in doping practices, weightlifting would benefit from
the targeted testing of certain regions and continuing investment in long-term sample storage as the sensitivity
and specificity of detection continues to improve.
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Key points
 The nations with the highest number of sanctioned
weightlifters between 2008 and 2019 (the worst
period of doping in weightlifting’s history) all had at
least one overrepresented detected substance that
accounted for 38–60% of all detected substances.
 Improvements in the detection window for
exogenous anabolic androgenic steroids resulted in
samples from the 2008 and 2012 Olympic Games
being re-analysed and 61 weightlifters produced
retrospective Anti-Doping Rule Violations with the
highest number of medallists (34) across all sports.
 These findings suggest that weightlifting would
benefit from the targeted testing of certain regions
and further invest in long-term sample storage at
other major competitions (i.e. World and Continen-
tal Companionships).
Introduction
By June 2017, a targeted re-analysis of samples collected
from the Beijing 2008 and London 2012 Olympic
Games, in which a total of 515 weightlifters competed,
had resulted in thirty weightlifters having their medals
rescinded as they had retrospectively been identified to
have committed an anti-doping rule violation (ADRV)
[1, 2]. At this time Thomas Bach, the International
Olympic Committee (IOC) President, said weightlifting
had ‘a massive doping problem’ [3] and the IOC Execu-
tive Board instructed the International Weightlifting
Federation (IWF) to demonstrate by December 2017
that it had addressed, or had put in place plans to ad-
dress, the serious incidence of doping if the sport was to
be considered for inclusion in the 2024 Olympic Games
[4]. This targeted reanalysis took advantage of improve-
ments in the detection window of exogenous Anabolic
Androgenic Steroids (AAS) via the discovery of long-
term metabolites (LTMs) [5] for compounds such as
Metandienone [6], Dehydrochloromethyltestosterone [7]
and Stanozolol [8].
In response, the IWF created two new independent
commissions to advise on anti-doping policy changes
which respectively became the Clean Sport and Sport
Programme Commissions [9, 10]. Additionally, the IWF
started a series of actions to combat doping and in 2017
announced 1-year suspensions for nine Member Federa-
tions (MFs) found to have had three or more ADRVs
from the retesting of samples taken at the 2008 and
2012 Olympic Games [11]. The IWF also enforced a
new qualification system for the Tokyo 2020 Olympic
Games [12], and each athlete must compete in a mini-
mum of six eligible events that occur within defined
time frames to increase the likelihood of being tested in-
competition prior to the Olympic Games. This will
include at least one event between October 1, 2020, and
April 30, 2021, to account for the coronavirus pandemic
delaying the Olympic Games [12, 13]. The IWF also an-
nounced limitations on MFs for participants per country
for the 2020 Olympic Games based on the MFs doping
record since the start date of the 2008 Olympic Games
and the end of the 2020 qualification period [12]. MFs
that had 20 or more ADRVs would be able to send only
one male and one female athlete in total; MFs that re-
corded 10–19 ADRVs would be eligible to send two
male and two female athletes; and MFs with less than
ten ADRVs would be eligible to send four male and four
female athletes [12]. The IWF also signed an agreement
with the International Testing Agency (ITA) to take re-
sponsibility for key areas of its anti-doping programme,
and once this partnership was finalised the IOC lifted
the conditional status of weightlifting for the 2024
Olympic Games, citing the positive steps taken by the
IWF to combat doping [14, 15]. However, the IOC still
reserves its right to review weightlifting’s place on the
2024 Olympic Games Programme, due to the recent rev-
elations of anti-doping corruption in the sport [16].
The Hungarian Anti-Doping Group (HUNADO), who
carried out a large proportion of the anti-doping tests
requested by the IWF in the last decade, and both the
IWF and ex-President Tamás Aján, who’s tenure started
in 2000, have had recent accusations of anti-doping cor-
ruption with irregularities in Out of Competition (OOC)
testing, urine sample manipulation and the disappear-
ance of positive doping results [17] which eventually re-
sulted in Aján’s resignation in April 2020 [18]. An
independent report concluded that HUNADO had acted
in accordance with World Anti-Doping Agency
(WADA) standards [19]. However, the report concluded
that former President Tamás Aján had breached confi-
dential information for the planned dates of OOC test-
ing potentially leaking this information to certain
nations or athletes [19]. The IWF also deliberately de-
layed notifying 18 Azerbaijani athletes of their ADRVs,
thus enabling them to win medals at international com-
petitions in 2013 [19]. The report also identified that 21
Turkish weightlifters provided samples resulting in Ad-
verse Analytical Findings (AAFs) during OOC tests, but
they were not followed through appropriately as al-
though the IWF president was notified of these AAFs
the athletes continued competing and winning medals
[19]. These cases, plus 41 hidden cases and 10 possible
other cases where the AAFs have not been followed
through have been forwarded onto WADA for further
investigation [19]. The investigative team also found evi-
dence that an additional 130 samples had been taken
but not processed [20]. This was information absent
from the original report due to insufficient time to in-
vestigate prior to the report deadline [20]. Due to the
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WADA and the ITA investigation currently being open
on this case, it is not publicly known how many ADRVs
these unprocessed samples relate to, with WADA ‘moni-
toring this closely to ensure no case is left unprocessed’
[20].
The aim of this analysis of the doping practices of
international weightlifters is to aid the sport fight doping
as its ongoing commitment to clean sport is required to
allow the sport to be on the 2024 Olympic Games
Programme [16]. Even though WADA and ITA investi-
gations are still open in regards to identifying the full ex-
tent in which AAFs have been hidden by the ex-IWF
president, an analysis of salient prohibited substances
noted in sanction data by geographical location can still
build a clearer picture of doping practices. This will aid
governing bodies and anti-doping authorities in identify-
ing regions with higher rates of doping for improved tar-
geted testing and educational programmes. Additionally,
investigating the prevalence of retrospectively identified
doping from the re-analysis of samples collected from
the Olympic Games will also show if the practice of
long-term sample storage has been successful in catch-
ing doping weightlifters.
Methods
Data entry
Data from 2008 to 2019 were obtained from the IWF
Sanction List publicly available on the IWF website [21]
in February 2020. For weightlifters who had announced
retrospective ADRVs from AAFs noted in the re-testing
of samples from either the 2008 or 2012 Olympic
Games, data were obtained from the IWF Sanction List
[21] and other publicly available web pages: IOC ‘Fight
Against Doping’ Press Releases [22], IOC [23, 24] and
IWF Event Results Pages [25, 26] and IWF Anti-Doping
News Archives [27] in mid-May 2020. All detected sub-
stance names were made uniform and identified to the
parent compound which generated the noted metabolite.
For classification of substances as a marker indicating
endogenous AAS (EAAS) usage, WADA technical docu-
ments were utilised [28]. These state that EAAS adminis-
tration can cause alterations in the markers of the urinary
steroid profile which is comprised of androsterone, etio-
cholanolone, 5α-androstane-3α,17β-diol (5αAdiol), 5β-
androstane-3α,17β-diol (5βAdiol), testosterone and epites-
tosterone. Additionally, the administration of testosterone
or its precursors, androstenediol, androstenedione, dehy-
droepiandrosterone or a testosterone metabolite, dihydro-
testosterone or a masking agent such as epitestosterone
are proven to alter one or more of the parameters of the
urinary steroid profile [29], and therefore, any mention of
a component of the urinary steroid profile or these sub-
stances was denoted as a marker of EAAS usage.
Each sanction was classified based on (1) the IWF
Continental Federation (Africa, Asia, Europe, Oceania,
Pan America) and (2) the category of the detected sub-
stance/prohibited method as described by the 2019
WADA Prohibited List [30]. Three sanctions were omit-
ted from any analyses that involved comparisons of, or
counts of, detected substances/prohibited methods be-
cause this information was absent or only the article
number that was violated by the Anti-Doping Policy of
the IWF was stated.
Statistical analysis
Fisher’s exact test was used to investigate if four IWF
Continental Federations (Europe, Africa, Asia, Pan
America) had differences in the detection of exogenous
AAS metabolites, markers indicating EAAS usage and
other substance metabolites, in a 4 × 3 matrix, from the
sanctions between 2008 and 2019 obtained from the
IWF Sanction List publicly available on the IWF website
[21] in February 2020. An adjusted alpha level of 0.05
was used with the Benjamini–Hochberg [31] false dis-
covery rate method for multiple comparisons. Data ana-
lysis was conducted using R version 3.6.3 [32] using the
tidyverse [33], data.table [34], rcompanion [35], choro-
plethr [36] and choroplethrMaps [37] packages. The data
files and R code used in this study have been made pub-
licly available online [38].
Results
The most frequently detected substances
Five hundred sixty-five Sanctioned Athletes/Athlete Sup-
port Personnel, across 83 different MF, were recorded
between 2008 and 2019 (Fig. 1). Five hundred sixty-two
of these sanctions had a named prohibited substance/
prohibited method noted. Five hundred fifty-nine of
these sanctions occurred due to the detection of prohib-
ited substances, with only three sanctions occurring due
to the use of prohibited methods (n = 2 urine substi-
tution, n = 1 blood substitution). Of these 559 sanc-
tions, 51 different substances were detected, from 10
different categories within the WADA Prohibited List,
with exogenous AAS metabolites and markers indicat-
ing EAAS usage accounting for 82% of detected sub-
stances (Fig. 2).
Three hundred ninety-six sanctions occurred from an
in-competition (IC) test and 167 from an OOC test with
two sanctions testing location undefined. From the ten
most detected substances, six substances, Dehydrochlor-
omethyltestosterone (89%), markers indicating EAAS
usage (76%), Metenolone (100%), Methylhexanamine
(100%), Methyltestosterone (71%) and Nandrolone (86%)
showed a higher instance of detection IC (Fig. 2).
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Prohibited substance usage and Continental Federation
Of the 565 Sanctioned Athletes/Athlete Support
Personnel counted 199 were from Asia, 267 from Eur-
ope, 34 from Africa and 65 from Pan America. There
were no sanctions from Oceania. From the 562 sanctions
that had the available data, the proportion of detected
substances that were classified as exogenous AAS,
markers of EAAS usage (i.e. the most detected substances)
and all other substance category types varied by IWF Con-
tinental Federation (p < 0.001). The proportions of these
detected substance types was significantly different be-
tween Asia (70%, 15%, 15%) and Pan America (37%, 30%,
33%) (p < 0.001), Asia and Africa (50%, 17%, 33%) (p =
0.039), Europe (74%, 11%, 15%), Pan America (p < 0.001),
and Europe and Africa (p = 0.015) with no differences be-
tween Asia and Europe or Pan America and Africa,
highlighting regional differences in detected prohibited
substances.
Prohibited substance usage and nation
For the 10 nations with the highest number of sanctions,
when looking at the 10 most detected substances, each
nation had at least one substance that accounted for
more than one third of all detected substances as fol-
lows: Azerbaijan (n = 35 sanctions) (Metandienone
38%), Kazakhstan (n = 35) (Stanozolol 51%), Russia (n =
32) (Dehydrochloromethyltestosterone 52%), Bulgaria (n
= 30) (Metandienone 42% and Stanozolol 45%), Belarus
(n = 23) (Stanozolol 44%), Armenia (n = 22) (Stanozolol
38%), Ukraine (n = 19) (Dehydrochloromethyltestoster-
one 40% and Stanozolol 40%), Romania (n = 18)
(Stanozolol 60%), Thailand (n = 18) (Metandienone 50%
and EAAS 50%) and Moldova (n = 17) (Dehydrochloro-
methyltestosterone 37%) (Fig. 3).
Most affected nations of 2008 and 2012 retesting
Sixty-one weightlifters, from 13 different countries, were
retrospectively announced to have committed an ADRV
for prohibited substances from the Beijing 2008 (n = 25)
and London 2012 (n = 36) Olympic Games. Sixteen of
these weightlifters (64%) from Beijing 2008 were medal-
lists (4 Gold, 5 Silver and 7 Bronze). For Beijing 2008
Kazakhstan and Azerbaijan had more athletes generate a
retrospective ADRV than those who did not and for
Belarus, Ukraine, Russia and Kazakhstan more medals
were won by athletes who generated a retrospective
ADRV than those who have not (Fig. 4). Eighteen of
these weightlifters (50%) from London 2012 were medal-
lists (5 gold, 5 silver and 8 bronze). For London 2012
Russia, Kazakhstan, Belarus, Azerbaijan and Armenia
had more athletes generate a retrospective ADRV than
those who have not and for both Romania and Moldova
all athletes that competed generated a retrospective
ADRV. All medallists from Ukraine, Kazakhstan,
Belarus, Romania, Azerbaijan, Armenia and Moldova
generated retrospective ADRVs and for Russia twice as
many medals were won by athletes who generated a
retrospective ADRV (Fig. 4).
Most affected categories of 2008 and 2012 retesting
From Beijing 2008, five weight categories (men’s u94kg,
women’s u48kg, women’s u69kg, women’s u75kg and
Fig. 1 The number of sanctions recorded from the IWF Sanction List [21] between 2008 and 2019 when it was accessed in February 2020 and
their geographical location. NA indicates zero-recorded sanctions. Five hundred sixty-five sanctions were recorded but 553 were used for the
creation of this figure as the following Member Federations (MF) were not present in the country.map dataset in the choroplethrMaps [36]
package in R: Puerto Rico (n = 3), Mauritius (n = 2), Palestine (n = 2), Seychelles (n = 2), Aruba (n = 1), Barbados (n = 1) and Bahrain (n = 1)
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women’s 75 kg+) and from London 2012, three weight
categories, (women’s u53kg, women’s u63kg and
women’s u69kg) had two medallists produce retrospect-
ive ADRVs from AAFs. In two instances from London
2012 (men’s u94kg and women’s u75kg), all medal win-
ners produced retrospective ADRVs from AAFs, with
the men’s u94kg category being the worst affected with
eight athletes generating retrospective ADRVs from
AAFs, six of whom originally placed in the top 10.
Detected substances from 2008 and 2012 retesting
In total, across both the Beijing 2008 and London
2012 Olympic Games, 94 prohibited substances were
detected in the re-tested samples with
Fig. 2 The 10 most detected substances from the IWF Sanction List [21] between 2008 and 2019 and if their detection occurred in-competition
(IC) or out-of-competition (OOC) with superscript numbers classifying substances based on the WADA 2019 Prohibited List: exogenous Anabolic
Androgenic Steroid (AAS)1, markers indicating endogenous AAS usage (EAAS)2, Specified Stimulants3 and Other Anabolic Agents4 [30].
Clenbuterol and Methyltestosterone are tied in 10th place with 14 occasions of detection each. One data point for Methandienone was omitted
as the testing location was not defined
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Dehydrochloromethyltestosterone and Stanozolol ac-
counting for 83% of all detected substances. The ma-
jority of retrospective ADRVs (58 of 61) were caused
by the detection of one of these two substances with
exogenous AAS accounting for 94% of all detected
substances. Across both Olympic Games, for the 10
nations with the highest number of announced retro-
spective ADRVs, the proportions of detected sub-
stances are shown in Fig. 5. For each nation there is
at least one substance that makes up ≥ 40% of all
detected substances as follows: Kazakhstan (n = 10
ADRVs) (Stanozolol 67%), Russia (n = 10) (Dehydro-
chloromethyltestosterone 71%), Belarus (n = 8)
(Dehydrochloromethyltestosterone 44%, Stanozolol
44%), Azerbaijan (n = 6) (Dehydrochloromethyltes-
tosterone 67%), Armenia (n = 5) (Dehydrochloro-
methyltestosterone 50%, Stanozolol 50%), Turkey (n
= 5) (Stanozolol 71%), Romania (n = 4) (Metenolone
40%, Stanozolol 40%), Ukraine (n = 4) (Dehydro-
chloromethyltestosterone 100%), China (n = 3)
(Growth Hormone-Releasing Peptide-2 75%) and
Moldova (n = 3) (Dehydrochloromethyltestosterone
67%).
Discussion
The time period of this analysis has seen the highest num-
ber of sanctions in weightlifting’s history. It has also seen
an independent investigation into allegations of anti-
doping corruption finding the IWF president to have brea-
ched the confidentiality of the planned timing of OOC
sample collection, potentially giving advanced notice of
OOC testing to individual countries or athletes [19]. The
president also delayed the announcement of ADRVs from
18 Azerbaijani weightlifters and AAFs from 21 Turkish
weightlifters were not followed through appropriately, en-
abling them to win medals in international events. Investi-
gations by WADA and the ITA are still pending on an
additional ‘41 hidden cases and 10 possible other cases
where the AAFs have not been followed through’ [19] and
on 130 unprocessed samples (in which the number of
AAFs is unknown) [20]. Despite these ongoing investiga-
tions, this study intended to build a clearer picture of dop-
ing practices of weightlifters and how these practices
varied across the IWF Continental Federations, based on
known sanction data, to enhance future doping detection
and to investigate the re-testing of samples collected at
the 2008 and 2012 Olympic Games.
Fig. 3 The 10 nations with the highest number of sanctions, from the IWF Sanction List [21] between 2008 and 2019 and for the 10 most
detected substances the percentage of times they were detected. Other* denotes either Methyltestosterone, Clenbuterol, Metenolone,
Oxandrolone, Boldenone, Methylhexanamine or Nandrolone. EAAS, markers indicating endogenous AAS usage. AZE Azerbaijan, KAZ Kazakhstan,
RUS Russia, BUL Bulgaria, BLR Belarus, ARM Armenia, UKR Ukraine, ROU Romania, THA Thailand, MDA Moldova
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Over an 11-year period, exogenous AAS metabolites
and markers indicating EAAS usage accounted for 82%
of detected substances from the IWF Sanction List. The
effects of AAS on increasing skeletal muscle mass and
strength have been well documented [39–44], and these
ergogenic benefits are a likely reason for their preference
of usage by doping athletes who compete in a strength
sport. Europe generated the highest number of sanctions
(n = 267) followed by Asia (n = 199), Pan America (n =
65) and Africa (n = 34), with no sanctions from Oceania
recorded. During this time frame, weightlifting has been
most popular in Europe and Asia, but globally popularity
has been expanding with the senior 2019 Oceania [45],
African [46] and Pan American [47] Championships
hosting 129, 112 and 187 weightlifters, respectively,
whilst the senior 2019 European [48] and Asian [49]
Championships hosted 322 and 214 weightlifters,
respectively.
The proportions of detected exogenous AAS metabo-
lites, markers indicating EAAS usage and all other sub-
stance category types varied by IWF Continental
Federation. Europe and Asia both respectively showed
statistically different (p < 0.05) proportions of detection
for these three substance types compared to both Africa
and Pan America with exogenous AAS showing the lar-
gest difference in the proportion of substance types de-
tected. The most detected exogenous AAS were
Stanozolol, Metandienone and Dehydrochloromethyltes-
tosterone. At the national level there is also differences
in the detection of substances as when looking at the 10
most detected substances, from the 10 nations with the
highest numbers of sanctions, there is at least one
Fig. 4 The number of weightlifters that competed from each nation announced to have given retrospective Anti-Doping Rule Violations (ADRVs)
via Adverse Analytical Findings (AAFs) from the re-testing of samples collected at the Beijing 2008 and London 2012 Olympic Games. Numbers
inside the bars show the number of original medallists. Weightlifters with announced retrospective ADRVs who did not start are included. In
Beijing 2008, one athlete from UKR produced an AAF from an in-competition sample and is excluded in these counts. CHN China, BLR Belarus,
UKR Ukraine, RUS Russia, ARM Armenia, KAZ Kazakhstan, AZE Azerbaijan, TUR Turkey, MDA Moldova, UZB Uzbekistan, UKR Ukraine, ROU Romania,
ALB Albania, GEO Georgia
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substance overrepresented that accounts for 38–60% of
detected substances in these countries (Fig. 3). The cul-
tural preference of certain doping substances at the re-
gional/national level is likely heavily confounded by
regional/national drug availability (legally or illicitly).
Nationally, the continued usage of certain substances
could be decentralized (e.g. athletes’ independent choice
based on availability) or centralized (i.e. state-sponsored
doping). Making inferences on the cause of substance
over-representation from substance detection data is not
possible, but identifying these patterns is useful know-
ledge for anti-doping authorities as they could use this
data for targeted educational programmes to illicit the
change required to change these patterns. These pat-
terns corroborate with the notion from the independent
report into Anti-doping corruption into weightlifting
that although the ex-president ‘interfered with the IWF
Anti-Doping Commission, the real problem is the cul-
ture of doping that exists in the sport.’ [19]. Additionally,
these geographic differences in doping practices could
better inform targeted testing applied by anti-doping au-
thorities and targeted investigations into other ways of
identifying ADRVs such as trafficking, aiding/abetting
and complicity. For effective doping control, inter-
national sporting authorities should have anti-doping
programmes that frequently conduct unannounced
OOC testing, across all regions of the globe, to catch
doping athletes who intend for prohibited metabolites to
clear their urine prior to anticipated IC tests. With Eur-
ope and Asia showing the highest number of sanctions
and highest prevalence in the usage of exogenous AAS
an extra emphasis on OOC testing in these regions may
be warranted in weightlifting as these substances are
likely to be used in training prior to competition where
anticipated testing occurs. Additionally, if athletes from
these regions now consider that the likelihood of getting
caught using exogenous AAS is now high due to their
high detection prevalence they may now start to use
other performance enhancing drugs (PEDs) with shorter
detection windows meaning that OOC testing is even
more important.
The decision of the IOC to store athletes’ samples col-
lected from Olympic Games for 10 years has proven par-
ticularly fruitful for catching doping medallists in
weightlifting. This analysis of re-tested samples has
shown that the intention of doping athletes who ceased
Fig. 5 The 10 nations with the highest number of announced retrospective Anti-Doping Rule Violations via Adverse Analytical Findings from
both the Beijing 2008 and London 2012 Olympic Games and the percentages of detected substances identified. Other* denotes either
Drostanolone, Erythropoietin, Oxandrolone, Sibutramine or Tamoxifen. GHRP2 Growth Hormone-Releasing Peptide-2, KAZ Kazakhstan, RUS Russia,
BLR Belarus, AZE Azerbaijan, ARM Armenia, TUR Turkey, ROU Romania, UKR Ukraine, CHN China, MDA Moldova
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the usage of exogenous AAS prior to the 2008 and 2012
Olympic Games with the aim of diagnostic metabolites
clearing their urine prior to an anticipated test was suc-
cessful (with the known metabolites and detection sci-
ence at the time of these Olympic Games). However,
once the LMTs for exogenous AAS were discovered via
improvements in highly sensitive detection methods
employing chromatographic/mass spectrometric tech-
niques [5], a doubling of the detection window [6, 8] oc-
curred for some exogenous AAS and subsequently 34
medallists were caught doping retrospectively when
these samples were reanalysed. From the sixty-one retro-
spective ADRVs identified via re-testing, the exogenous
AAS Dehydrochloromethyltestosterone and Stanozolol
accounted for 83% of detected substances with 95% of
announced athlete ADRVs noting at least one of these
substances. These findings should send a strong deter-
rent to prospective doping athletes that, due to LMT
discovery, the detection window of these substances has
substantially improved and the doping practices of ath-
letes in the runup to the 2008 and 2012 Games may not
be possible anymore for future competitions. The IOC
has announced that the ITA has planned the ‘most com-
prehensive pre-Games testing programme ever con-
ducted’ for Tokyo 2020 and that $5 million, spread over
10 years, will be allocated to a comprehensive long-term
storage programme [50, 51], potentially acting as a
stronger deterrent to prospective doping weightlifters.
However, a long-term storage is not standard across
Continental Games, with the International Federations
(IF) having to fund the cost of a long-term storage [52].
Based on the success shown with weightlifting, the IWF
and other IF should further their investment in a long-
term sample storage at Continental Games and other
important international competitions. Other categories
of PEDs that may currently have shorter detection win-
dows may be used instead of exogenous AAS by weigh-
tlifters, or other athletes in strength/power sports (e.g.
EAAS), due to this improved detectability in exogenous
AAS, but these shorter detection windows could im-
prove in the future (e.g. by advances in the steroidal
module of the athlete biological passport), and thus, a
long-term sample storage would enable a re-analysis of
samples with improved detectability.
Conclusion
This analysis of doping practices, over a period of 11
years, has shown avenues that may enhance the future
detection of doping weightlifters. For example, with Eur-
ope and Asia producing the highest numbers of sanc-
tioned weightlifters, as well as the highest prevalence in
the detection of exogenous AAS, higher rates of targeted
OOC testing in these regions may be warranted, both in
the instance that these substances continued to be used
or if a transition is made to substances with shorter de-
tection windows. Educational programmes on anti-
doping may also be required to change the behaviour in
nations with the highest number of sanctions especially
focussing on detected substances that are overrepre-
sented in their doping weightlifters. Lastly, the preva-
lence of retrospectively identified doping at the Beijing
and London Olympic Games shows that the long-term
storage of samples should continue, with the aim of in-
creasing this practice at additional competitions to the
Olympic Games, as anti-doping science continues to im-
prove its detection methods.
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